BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 14683477)

  • 1. The role of estrogen and estrogen-related drugs in cardiovascular diseases.
    Ogita H; Node K; Kitakaze M
    Curr Drug Metab; 2003 Dec; 4(6):497-504. PubMed ID: 14683477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective estrogen receptor modulators--a new age of estrogens in cardiovascular disease?
    Guzzo JA
    Clin Cardiol; 2000 Jan; 23(1):15-7. PubMed ID: 10680024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiovascular effects of selective estrogen receptor modulators. Current perspectives].
    Simoncini T; Mannella P; Genazzani AR
    Recenti Prog Med; 2003 Feb; 94(2):51-6. PubMed ID: 12908369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug targeting of estrogen receptor signaling in the cardiovascular system: preclinical and clinical studies.
    Sanz-González SM; Cano A; Valverde MA; Hermenegildo C; Andrés V
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Apr; 2(2):107-22. PubMed ID: 15320794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of cardiac hypertrophy by estrogens.
    Pelzer T; Shamim A; Wölfges S; Schumann M; Neyses L
    Adv Exp Med Biol; 1997; 432():83-9. PubMed ID: 9433514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of estrogens, selective estrogen receptor modulators and phytoestrogens in cardiovascular protection.
    Herrington D
    Can J Cardiol; 2000 Aug; 16 Suppl E():5E-9E. PubMed ID: 10906617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy: current controversies.
    Davison S; Davis SR
    Clin Endocrinol (Oxf); 2003 Mar; 58(3):249-61. PubMed ID: 12608928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogens and Coronary Artery Disease: New Clinical Perspectives.
    Meyer MR; Barton M
    Adv Pharmacol; 2016; 77():307-60. PubMed ID: 27451102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and evolving approaches to individualizing estrogen receptor-based therapy for menopausal women.
    Santen RJ; Kagan R; Altomare CJ; Komm B; Mirkin S; Taylor HS
    J Clin Endocrinol Metab; 2014 Mar; 99(3):733-47. PubMed ID: 24423357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging selective estrogen receptor modulators: special focus on effects on coronary heart disease in postmenopausal women.
    Vogelvang TE; van der Mooren MJ; Mijatovic V; Kenemans P
    Drugs; 2006; 66(2):191-221. PubMed ID: 16451093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone therapy and selective estrogen receptor modulators for prevention of coronary heart disease in postmenopausal women estrogen replacement from the cardiologist's perspective.
    Mobasseri S; Liebson PR; Klein LW
    Cardiol Rev; 2004; 12(6):287-98. PubMed ID: 15476565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HRT and SERMs: the good, the bad...and the lovely?
    Sandberg K
    Trends Endocrinol Metab; 2002 Oct; 13(8):317-8. PubMed ID: 12217481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of selective estrogen receptor modulators (SERMs) in postmenopausal health.
    Draper MW
    Ann N Y Acad Sci; 2003 Nov; 997():373-7. PubMed ID: 14644844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of estrogen and selective estrogen receptor modulators on cardiovascular risk factors.
    Walsh BW
    Ann N Y Acad Sci; 2001 Dec; 949():163-7. PubMed ID: 11795349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of estrogens and selective estrogen receptor modulators on indicators of cardiovascular health in postmenopausal women.
    Klein KP; Herrington DM
    Medscape Womens Health; 2002; 7(5):2. PubMed ID: 12466731
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of SERM on breast cancer and cardiovascular disease: making a comparison between raloxifene use and hormone replacement therapy on the risks of the diseases].
    Higuchi T; Mizunuma H
    Clin Calcium; 2004 Oct; 14(10):81-4. PubMed ID: 15577136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indications for hormone replacement therapy].
    Birkhäuser MH
    Ther Umsch; 2000 Oct; 57(10):635-42. PubMed ID: 11081375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormonal replacement therapy and selective estrogen receptor modulators in prevention of cardiovascular disease].
    Kozakiewicz K; Wycisk A
    Wiad Lek; 2006; 59(5-6):377-82. PubMed ID: 17017486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.